Showing 1 - 6 results of 6 for search 'L. Mortier', query time: 0.01s
Refine Results
-
1
-
2
The RoMEO study: a real-world, observational, prospective investigation of dabrafenib and trametinib combination treatment in patients with BRAF V600 unresectable or metastatic cut... by L. Mortier, N. Meyer, J.-J. Grob, M. Pouriel, D. de Carpentier, P. Saïag
Published 2024-01-01
Article -
3
Efficacy and safety of cemiplimab in cutaneous squamous cell carcinoma on chronic wounds: A French retrospective study by M. Antoszczak, E. Maubec, A.-B. Duval-Modeste, A. Jannic, C. Jacobzone-Leveque, R. Lesbazeilles, F. Skowron, D. Solub, J. Ancel, L. Mortier, M. Viguier
Published 2024-12-01
Article -
4
Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France by S. Dalle, P. Saiag, C. Lebbé, J.-J. Grob, B. Dréno, S. Dalac, B. Asselain, F. Skowron, S. Darras, N. Jovenin, G. Quereux, A. Khammari, C. Rieuf, F. Brellier, S. Houssou, L. Mortier
Published 2024-01-01
Article -
5
Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets by B. Louveau, I. Nakouri, F. Jouenne, B. Baroudjian, A. Sadoux, L. Da Meda, A. Osio, F. Reinhart, J. Robert, M. Mancini, F. Herms, B. Cribier, L. Mortier, T. Jouary, N. Basset-Seguin, C. Lebbé, S. Mourah, M. Battistella
Published 2024-01-01
Article -
6
Early recurrence in a pooled international cohort of melanoma patients treated with adjuvant nivolumab in a real-world setting by L. Mortier, R. Gutzmer, V. Atkinson, S. Dalle, P. Saiag, B. Neyns, A. Rorive, P. Parente, M. Weichenthal, J.-J. Grob, C. Lebbé, P. Mohr, T. Eigentler, L. McDonald, L. Willemot, F. Brellier, O. Bakharevski, S. Houssou, M. Jadhao, D. Schadendorf
Published 2024-01-01
Article